Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Julie Smith Insider Profile

4 Followers

Julie Smith, Director at Stoke Therapeutics, holds ― shares in Stoke Therapeutics (Ticker: STOK), holds 28.96K shares in Exelixis (Ticker: EXEL), holds 37.95K shares in Raptor Pharmaceutical Corp. (Ticker: RPTP).

Julie Smith's Trading History

EXELExelixis		May 29, 2026DirectorUninformative Buy―$2.01M
RPTPRaptor Pharmaceutical Corp.		Feb 11, 2016―Uninformative Buy―$341.55K
~BOLDAudentes Therapeutics		――――
STOKStoke Therapeutics		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Julie Smith insider profile FAQ

What is the percentage of profitable transactions made by Julie Smith?
The percentage of profitable transactions made by Julie Smith is 0%.
What is the average return per transaction made by Julie Smith?
The average return per transaction made by Julie Smith is -52.80%.
What stocks does Julie Smith hold?
Julie Smith holds: STOK, EXEL, RPTP, ~BOLD stocks.
What was Julie Smith's most profitable transaction?
Julie Smith’s most profitable transaction was an Informative Sell of EXEL stock on February 28, 2025. The return on the trade was -13.80%.
What is Julie Smith's role in Stoke Therapeutics?
Julie Smith's role in Stoke Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.